Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Gkitsas N"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Klysz DD; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Fowler C; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Malipatlolla M; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Stuani L; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Freitas KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Chen Y; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Meier S; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Daniel B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA, USA., Sandor K; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Xu P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Huang J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Labanieh L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Keerthi V; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Leruste A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Bashti M; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mata-Alcazar J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Gkitsas N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Guerrero JA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Fisher C; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Asano K; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Davis KL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Satpathy AT; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Feldman SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Medicine, Division of Bone Marrow Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: cmackall@stanford.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Feb 12; Vol. 42 (2), pp. 266-282.e8. Date of Electronic Publication: 2024 Jan 25.
Autor:
Balke-Want H; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Keerthi V; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Gkitsas N; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Mancini AG; MaxCyte, Inc, Rockville, MD, USA., Kurgan GL; Integrated DNA Technologies, Inc, Coralville, IA, 52241, USA., Fowler C; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Xu P; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Liu X; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Asano K; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Patel S; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Fisher CJ; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Brown AK; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Tunuguntla RH; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Patel S; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Sotillo E; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Mackall CL; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. cmackall@stanford.edu., Feldman SA; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. feldmans@stanford.edu.
Publikováno v:
Molecular cancer [Mol Cancer] 2023 Jun 26; Vol. 22 (1), pp. 100. Date of Electronic Publication: 2023 Jun 26.
Autor:
Klysz DD; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Fowler C; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Malipatlolla M; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Stuani L; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, California., Freitas KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Meier S; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Pathology, Stanford University School of Medicine, Stanford, California.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, California., Daniel B; Department of Pathology, Stanford University School of Medicine, Stanford, California.; Center for Personal Dynamic Regulomes, Stanford University, Stanford, California., Sandor K; Department of Pathology, Stanford University School of Medicine, Stanford, California., Xu P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Huang J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Labanieh L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Leruste A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Bashti M; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Keerthi V; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Mata-Alcazar J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Gkitsas N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Guerrero JA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Fisher C; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Asano K; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Davis KL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, California., Satpathy AT; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Pathology, Stanford University School of Medicine, Stanford, California., Feldman SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Pediatrics, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Deparment of Medicine, Division of Bone Marrow Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, California.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 25. Date of Electronic Publication: 2023 Apr 25.
Autor:
Balke-Want H; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA., Keerthi V; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA., Cadinanos-Garai A; USC/CHLA Cell Therapy Program, University of Southern California, and Children's Hospital Los Angeles, Los Angeles, USA., Fowler C; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA., Gkitsas N; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA., Brown AK; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA., Tunuguntla R; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA., Abou-El-Enein M; USC/CHLA Cell Therapy Program, University of Southern California, and Children's Hospital Los Angeles, Los Angeles, USA.; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA., Feldman SA; Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, USA.
Publikováno v:
Immuno-oncology technology [Immunooncol Technol] 2023 Mar 09; Vol. 18, pp. 100375. Date of Electronic Publication: 2023 Mar 09 (Print Publication: 2023).
Autor:
Cai Y; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Prochazkova M; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Jiang C; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Song HW; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Jin J; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Moses L; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Gkitsas N; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Somerville RP; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Highfill SL; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Panch S; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Stroncek DF; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA., Jin P; Department of Transfusion Medicine and Cellular Engineering, Center for Cellular Engineering, NIH Clinical Center, NIH, 10 Center Drive-MSC-1184, Building 10, Room 3C720, Bethesda, MD, 20892-1184, USA. PJin@mail.cc.nih.gov.
Publikováno v:
Journal of translational medicine [J Transl Med] 2021 Dec 24; Vol. 19 (1), pp. 523. Date of Electronic Publication: 2021 Dec 24.
Autor:
Spiegel JY; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Muffly L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Hossain NM; Division of Hematology/Oncology, Loyola University Medical Center, Chicago, IL, USA., Oak J; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA., Baird JH; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Shiraz P; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Craig J; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Iglesias M; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Younes S; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA., Natkunam Y; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA., Ozawa MG; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA., Yang E; Department of Clinical Pathology, Stanford University School of Medicine, Stanford, CA, USA., Tamaresis J; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Chinnasamy H; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Ehlinger Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Reynolds W; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Lynn R; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Lyell Immunopharma, San Francisco, CA, USA., Rotiroti MC; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA., Gkitsas N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Johnston L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Lowsky R; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Majzner RG; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA., Meyer E; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Negrin RS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Rezvani AR; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Shizuru J; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Weng WK; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Mullins C; Adaptive Biotechnologies, Seattle, WA, USA., Jacob A; Adaptive Biotechnologies, Seattle, WA, USA., Kirsch I; Adaptive Biotechnologies, Seattle, WA, USA., Bazzano M; IsoPlexis, Brantford, CT, USA., Zhou J; IsoPlexis, Brantford, CT, USA., Mackay S; IsoPlexis, Brantford, CT, USA., Bornheimer SJ; BD Biosciences, San Jose, CA, USA., Schultz L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA.; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Ramakrishna S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA., Davis KL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA., Kong KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Shah NN; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Qin H; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Fry T; Pediatric Oncology Branch Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.; Department of Pediatrics-Hematology/Oncology, University of Colorado Anschutz and Children's Hospital Colorado, Denver, CO, USA., Feldman S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Pediatrics-Hematology/Oncology, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.
Publikováno v:
Nature medicine [Nat Med] 2021 Aug; Vol. 27 (8), pp. 1419-1431. Date of Electronic Publication: 2021 Jul 26.
Autor:
Nagarsheth NB; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Norberg SM; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sinkoe AL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Adhikary S; Kite, A Gilead Company, Santa Monica, CA, USA., Meyer TJ; CCR Collaborative Bioinformatics Resource, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lack JB; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; NIAID Collaborative Bioinformatics Resource, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Warner AC; Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Schweitzer C; Kite, A Gilead Company, Santa Monica, CA, USA., Doran SL; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Korrapati S; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Stevanović S; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Trimble CL; Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA., Kanakry JA; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Bagheri MH; Radiology and Imaging Sciences Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Ferraro E; Office of the Clinical Director, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Astrow SH; Kite, A Gilead Company, Santa Monica, CA, USA., Bot A; Kite, A Gilead Company, Santa Monica, CA, USA., Faquin WC; Pathology Department, Massachusetts General Hospital, Boston, MA, USA., Stroncek D; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Gkitsas N; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Highfill S; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Hinrichs CS; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. ch977@cinj.rutgers.edu.
Publikováno v:
Nature medicine [Nat Med] 2021 Mar; Vol. 27 (3), pp. 419-425. Date of Electronic Publication: 2021 Feb 08.
Autor:
Chick, Robert Connor1 (AUTHOR) robert.chick@osumc.edu, Pawlik, Timothy M.1 (AUTHOR) tim.pawlik@osumc.edu
Publikováno v:
Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6419. 18p.
Autor:
Golikova, Elena A.1 (AUTHOR), Alshevskaya, Alina A.1 (AUTHOR) alkkina@yandex.ru, Alrhmoun, Saleh1,2 (AUTHOR), Sivitskaya, Natalia A.1 (AUTHOR), Sennikov, Sergey V.1,2 (AUTHOR)
Publikováno v:
Journal of Translational Medicine. 10/4/2024, Vol. 22 Issue 1, p1-17. 17p.